The stock's fall snapped a four-day winning streak.
Highlights,Charles Schwab Investment Management increased its holdings in Henry Schein, reaching close to 1% ...
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical ...
Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...
Investor's Business Daily on MSN1d
Henry Schein Shows Improved Relative Strength; Still Shy Of BenchmarkRating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...
Detailed price information for Dentsply Sirona Inc (XRAY-Q) from The Globe and Mail including charting and trades.
Piper Sandler analyst Jason Bednar maintained a Buy rating on Henry Schein (HSIC – Research Report) today and set a price target of ...
NasdaqGS:HSIC Earnings and Revenue History March 5th 2025 The Impact Of Unusual Items On Profit. For anyone who wants to understand Henry Schein's profit beyond the statutory numb ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Henry Schein Inc. closed 14.16% short of its 52-week high of $82.49, which the company reached on February 5th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback